Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Kardiologiia|January 1, 1993
[Long-term results of the program for preventing ischemic heart disease in Moscow (10-year follow-up study)]A M Kalinina, L V Chazova, L I Pavlova, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|March 1, 1992
[Eremomycin in the treatment of antibiotic-associated colitis in golden hamsters]A A Rukhlina, L A Malkova, L A Shevniuk, et al.
Clinical Immunology (Orlando, Fla.)|April 12, 2021
New laboratory criteria of the autoimmune inflammation in pulmonary sarcoidosis and tuberculosisA Malkova, A Starshinova, Y Zinchenko, et al.
Physiological Research|May 13, 2021
C-reactive protein, chemerin, fetuin-A and osteopontin as predictors of cardiovascular risks in persons with psoriasis vulgarisP Borsky, Z Fiala, C Andrys, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 22, 2017
[A retrospective analysis of the effect of pregnancy on the course of multiple sclerosis]E V Popova, D S Korobko, E V Bulatova, et al.
Kardiologiia|December 1, 1989
[Detection of ischemic heart disease in a survey of a male population 40-59 years of age (data of cooperative studies performed in Moscow, Kaunas, Kiev and Kharkov)]A M Kalinina, A V Baubinene, N A Vodianitskaia, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 3, 2017
[Clinical guidelines for the use of dimethyl fumarate in relapsing-remitting multiple sclerosis]V M Alifirova, A N Boiko, Ya V Vlasov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis]A N Boyko, K Z Bakhtiyarova, V A Dudin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 31, 2018
[Provision of alemtuzumab safety is one of the main components of pharmacovigilance]N V Khachanova, K Z Bakhtiyarova, A N Boyko, et al.
Chemmedchem|April 3, 2023
5-Alkoxy-1-aryl-3-polyfluoroalkylpyrazoles with Antinociceptive Activity: Partial Agonists of TRPV1 Ion ChannelsOlga G Khudina, Yanina V Burgart, Natalia A Malkova, et al.
Pageof 7